Literature DB >> 29656135

Two cases of disseminated infection following live organism anti-cancer vaccine administration in cancer patients.

James D Denham1, Dae Hyun Lee2, Manuel Castro3, Shuchi Pandya4, Sadaf Aslam5, Sowmya Nanjappa6, John N Greene7.   

Abstract

Vaccines containing live attenuated bacterial or viral organisms are currently being investigated as potential therapy for locally advanced or metastatic cancers. However, the use of such live organisms in an immunocompromised population, such as patients who recently or are currently receiving chemotherapy, raises the concern that these organisms can themselves disseminate and cause frank infection. We report a hereunto unreported phenomenon of anti-cancer vaccines (containing live attenuated organisms) leading to frank, disseminated infection. We submit that occurrence of this phenomenon must be watched for by all members of the interdisciplinary cancer treatment team.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Adenovirus; Anti-cancer vaccine; Listeria monocytogenes; Vaccine-induced disease

Mesh:

Substances:

Year:  2018        PMID: 29656135     DOI: 10.1016/j.ijid.2018.04.004

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity.

Authors:  Zachary T Morrow; Zachary M Powers; John-Demian Sauer
Journal:  Curr Clin Microbiol Rep       Date:  2019-11-20

2.  Vaccine strain Listeria monocytogenes bacteremia occurring 31 months after immunization.

Authors:  Elias Fares; Cindy B McCloskey; Andres Gutierrez; Michael Princiotta; Linda J Salinas; Douglas A Drevets
Journal:  Infection       Date:  2018-11-14       Impact factor: 7.455

3.  RIPK3 and Caspase-1/11 Are Necessary for Optimal Antigen-Specific CD8 T Cell Response Elicited by Genetically Modified Listeria monocytogenes.

Authors:  Aamir Rana; Felipe Campos de Almeida; Henry A Paico Montero; Maryanne M Gonzales Carazas; Karina R Bortoluci; Subash Sad; Gustavo P Amarante-Mendes
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

4.  Safety evaluation of the canine osteosarcoma vaccine, live Listeria vector.

Authors:  Margaret L Musser; Erika P Berger; Chelsea D Tripp; Craig A Clifford; Philip J Bergman; Chad M Johannes
Journal:  Vet Comp Oncol       Date:  2020-08-17       Impact factor: 2.613

Review 5.  Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress.

Authors:  John C Flickinger; Ulrich Rodeck; Adam E Snook
Journal:  Vaccines (Basel)       Date:  2018-07-25

6.  Vaccine strain Listeria monocytogenes abscess in a dog: a case report.

Authors:  Margaret L Musser; Erika P Berger; Cameron Parsons; Sophia Kathariou; Chad M Johannes
Journal:  BMC Vet Res       Date:  2019-12-21       Impact factor: 2.741

Review 7.  Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies.

Authors:  Mariam Oladejo; Yvonne Paterson; Laurence M Wood
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.